These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11290769)

  • 1. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro.
    Horwood NJ; Elliott J; Martin TJ; Gillespie MT
    J Immunol; 2001 Apr; 166(8):4915-21. PubMed ID: 11290769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation.
    Udagawa N; Horwood NJ; Elliott J; Mackay A; Owens J; Okamura H; Kurimoto M; Chambers TJ; Martin TJ; Gillespie MT
    J Exp Med; 1997 Mar; 185(6):1005-12. PubMed ID: 9091574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.
    Horwood NJ; Udagawa N; Elliott J; Grail D; Okamura H; Kurimoto M; Dunn AR; Martin T; Gillespie MT
    J Clin Invest; 1998 Feb; 101(3):595-603. PubMed ID: 9449693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes.
    Shinoda K; Sugiyama E; Taki H; Harada S; Mino T; Maruyama M; Kobayashi M
    Bone; 2003 Oct; 33(4):711-20. PubMed ID: 14555277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis.
    Mirosavljevic D; Quinn JM; Elliott J; Horwood NJ; Martin TJ; Gillespie MT
    J Bone Miner Res; 2003 Jun; 18(6):984-93. PubMed ID: 12817750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
    Nagata N; Kitaura H; Yoshida N; Nakayama K
    Bone; 2003 Oct; 33(4):721-32. PubMed ID: 14555278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
    Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
    Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage.
    Khapli SM; Mangashetti LS; Yogesha SD; Wani MR
    J Immunol; 2003 Jul; 171(1):142-51. PubMed ID: 12816992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro.
    Balani D; Aeberli D; Hofstetter W; Seitz M
    Arthritis Rheum; 2013 Feb; 65(2):436-46. PubMed ID: 23124514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
    J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
    Gorny G; Shaw A; Oursler MJ
    Exp Cell Res; 2004 Mar; 294(1):149-58. PubMed ID: 14980510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-18 inhibits TNF-alpha-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo.
    Morita Y; Kitaura H; Yoshimatsu M; Fujimura Y; Kohara H; Eguchi T; Yoshida N
    Calcif Tissue Int; 2010 Mar; 86(3):242-8. PubMed ID: 20111957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
    Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
    Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
    Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
    J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation.
    Suda K; Udagawa N; Sato N; Takami M; Itoh K; Woo JT; Takahashi N; Nagai K
    J Immunol; 2004 Feb; 172(4):2504-10. PubMed ID: 14764723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony-stimulating factor-dependent CD11c-positive cells differentiate into active osteoclasts.
    Ruef N; Dolder S; Aeberli D; Seitz M; Balani D; Hofstetter W
    Bone; 2017 Apr; 97():267-277. PubMed ID: 28161590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFα inhibits the development of osteoclasts through osteoblast-derived GM-CSF.
    Atanga E; Dolder S; Dauwalder T; Wetterwald A; Hofstetter W
    Bone; 2011 Nov; 49(5):1090-100. PubMed ID: 21884837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells.
    Stober D; Schirmbeck R; Reimann J
    J Immunol; 2001 Jul; 167(2):957-65. PubMed ID: 11441104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.